Prognosys Biosciences

(This story has been updated to correct a description of the company's technology.)
Prognosys Biosciences has developed a cDNA-based system for coding customized peptide libraries and has begun offering it commercially as a research tool.

The European Bioinformatics Institute has launched the Enzyme Portal, a free resource for researchers studying the biology of enzymes and proteins with enzymatic activity.

Febit plans to debut the method at Cambridge Healthtech Institute's Next-Generation Sequencing conference in San Diego next month.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.